803 related articles for article (PubMed ID: 9309537)
1. Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats.
Huang TS
J Endocrinol Invest; 1997; 20(7):393-6. PubMed ID: 9309537
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin secretagogues facilitate recovery of the hypothalamus-pituitary-adrenal axis suppressed by prolonged treatment with dexamethasone.
Huang TS
Metabolism; 1994 May; 43(5):544-8. PubMed ID: 8177041
[TBL] [Abstract][Full Text] [Related]
3. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.
Calogero AE; Kamilaris TC; Johnson EO; Tartaglia ME; Chrousos G
Endocrinology; 1990 Oct; 127(4):1574-9. PubMed ID: 2169393
[TBL] [Abstract][Full Text] [Related]
4. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
[TBL] [Abstract][Full Text] [Related]
5. Effects of fetal ethanol exposure on pituitary-adrenal sensitivity to secretagogues.
Osborn JA; Yu C; Stelzl GE; Weinberg J
Alcohol Clin Exp Res; 2000 Jul; 24(7):1110-9. PubMed ID: 10924017
[TBL] [Abstract][Full Text] [Related]
6. Chronic stimulation of the hypothalamus-pituitary-adrenal axis in rats by interleukin 1beta: central and peripheral mechanisms.
van der Meer MJ; Sweep CG; Pesman GJ; Tilders FJ; Hermus AR
Cytokine; 1996 Dec; 8(12):910-9. PubMed ID: 9050749
[TBL] [Abstract][Full Text] [Related]
7. Combined dexamethasone/CRH test in rats: hypothalamo-pituitary-adrenocortical system alterations in aging.
Hatzinger M; Reul JM; Landgraf R; Holsboer F; Neumann I
Neuroendocrinology; 1996 Nov; 64(5):349-56. PubMed ID: 8930935
[TBL] [Abstract][Full Text] [Related]
8. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
[TBL] [Abstract][Full Text] [Related]
9. Prenatal exposure to dexamethasone alters hippocampal drive on hypothalamic-pituitary-adrenal axis activity in adult male rats.
Shoener JA; Baig R; Page KC
Am J Physiol Regul Integr Comp Physiol; 2006 May; 290(5):R1366-73. PubMed ID: 16397092
[TBL] [Abstract][Full Text] [Related]
10. The site of inhibitory action of a natural (corticosterone) and synthetic steroid (dexamethasone) in the hypothalamic-pituitary-adrenal axis.
Sakakura M; Yoshioka M; Kobayashi M; Takebe K
Neuroendocrinology; 1981 Mar; 32(3):174-8. PubMed ID: 6261179
[TBL] [Abstract][Full Text] [Related]
11. Blunted pituitary-adrenocortical stress response in adult rats following neonatal dexamethasone treatment.
Felszeghy K; Bagdy G; Nyakas C
J Neuroendocrinol; 2000 Oct; 12(10):1014-21. PubMed ID: 11012843
[TBL] [Abstract][Full Text] [Related]
12. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.
Tizabi Y; Aguilera G
Neuroendocrinology; 1992 Nov; 56(5):611-8. PubMed ID: 1336816
[TBL] [Abstract][Full Text] [Related]
13. Impact of Hydrocortisone and of CRH Infusion on the Hypothalamus-Pituitary-Adrenocortical Axis of Septic Male Mice.
Téblick A; De Bruyn L; Van Oudenhove T; Vander Perre S; Pauwels L; Derde S; Langouche L; Van den Berghe G
Endocrinology; 2022 Jan; 163(1):. PubMed ID: 34698826
[TBL] [Abstract][Full Text] [Related]
14. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic maternal dexamethasone treatment on the hormones of the hypothalamo-pituitary-adrenal axis in the rat fetus.
Dupouy JP; Chatelain A; Boudouresque F; Conte-Devolx B; Oliver C
Biol Neonate; 1987; 52(4):216-22. PubMed ID: 2823915
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats.
Gil-Lozano M; Romaní-Pérez M; Outeiriño-Iglesias V; Vigo E; González-Matías LC; Brubaker PL; Mallo F
Endocrinology; 2014 Jul; 155(7):2511-23. PubMed ID: 24731096
[TBL] [Abstract][Full Text] [Related]
17. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat.
Calogero AE; Liapi C; Chrousos GP
J Endocrinol Invest; 1991 Apr; 14(4):277-86. PubMed ID: 1650804
[TBL] [Abstract][Full Text] [Related]
19. Enhanced glucocorticoid feedback inhibition of hypothalamo-pituitary-adrenal responses to stress in adult rats neonatally treated with dexamethasone.
Kamphuis PJ; Bakker JM; Broekhoven MH; Kunne C; Croiset G; Lentjes EG; Tilders FJ; van Bel F; Wiegant VM
Neuroendocrinology; 2002 Sep; 76(3):158-69. PubMed ID: 12218348
[TBL] [Abstract][Full Text] [Related]
20. Suppression of the hypothalamic-pituitary-adrenal axis after subcutaneous cortisone acetate administration in rats.
Mims RB
J Natl Med Assoc; 1977 Dec; 69(12):873-8. PubMed ID: 224195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
